Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction.
- DOI
- 10.1016/j.jhepr.2026.101817
- Published
- 2026-03-12
- Container
- JHEP Rep
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhepr.2026.101817,
title = {Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction.},
author = {Keenan BP and Fan Z and Le BK and Harris Q and Chen J and Clark M and Lea A and Zhang L and Cheung A and Lara F and Gordan JD and Bracci P and Behr SC and Fong L and Venook AP and Kim EJ and Kelley RK.},
year = {2026},
journal = {JHEP Rep},
doi = {10.1016/j.jhepr.2026.101817},
url = {https://doi.org/10.1016/j.jhepr.2026.101817}
}RIS
TY - JOUR TI - Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. AU - Keenan BP AU - Fan Z AU - Le BK AU - Harris Q AU - Chen J AU - Clark M AU - Lea A AU - Zhang L AU - Cheung A AU - Lara F AU - Gordan JD AU - Bracci P AU - Behr SC AU - Fong L AU - Venook AP AU - Kim EJ AU - Kelley RK. PY - 2026 JO - JHEP Rep DO - 10.1016/j.jhepr.2026.101817 UR - https://doi.org/10.1016/j.jhepr.2026.101817 ER -
APA
BP, K., Z, F., BK, L., Q, H., J, C., M, C., A, L., L, Z., A, C., F, L., JD, G., P, B., SC, B., L, F., AP, V., EJ, K., & RK., K. (2026). Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction.. JHEP Rep. https://doi.org/10.1016/j.jhepr.2026.101817
Source records
- europe-pmc · retrieved 2026-09-27T02:49:04.189Z
- doaj · retrieved 2026-09-27T02:49:04.183Z